Overall, compared with group non-pCR, patients in group pCR had the following significant characteristics: older age, lower CA153 in the peripheral blood, smaller tumor diameter and lower stage, higher Ki67 index, higher proportion of HER2-positive tumors, and lower percentage of HR-positive tumors (all the p-value <0.05). The gene discussed is ERBB2; the disease is neoplasm.